Table 3 Estimated mean rates of reduction in the ganglion cell-inner plexiform layer thickness: results from linear mixed models.
Control (μm/year, 95% CI) | p-value | No-DR (μm/year, 95% CI) | p-value | NPDR (μm/year, 95% CI) | p-value | p-value * (control vs. no-DR) | p-value * (control vs. NPDR) | p-value * (no-DR vs. NPDR) | |
|---|---|---|---|---|---|---|---|---|---|
Average | −0.277 (−0.445, −0.108) | 0.001 | −0.627 (−0.779, −0.475) | <0.0001 | −0.987 (−1.336, −0.637) | <0.0001 | 0.010 | 0.001 | 0.163 |
Superior | −0.301 (−0.577, −0.025) | 0.033 | −0.614 (−0.894, −0.335) | <0.0001 | −0.929 (−1.266, −0.592) | <0.0001 | 0.126 | 0.004 | 0.230 |
Superotemporal | −0.026 (−0.276, 0.223) | 0.834 | −0.588 (−0.771, −0.405) | <0.0001 | −0.806 (−1.181, −0.432) | <0.0001 | 0.001 | 0.0005 | 0.452 |
Inferotemporal | −0.308 (−0.641, 0.025) | 0.070 | −0.593 (−0.769, −0.417) | <0.0001 | −0.899 (−1.238, −0.561) | <0.0001 | 0.196 | 0.009 | 0.224 |
Inferior | −0.416 (−0.824, −0.009) | 0.045 | −0.573 (−0.834, −0.312) | <0.0001 | −1.039 (−1.479, −0.599) | <0.0001 | 0.614 | 0.034 | 0.151 |
Inferonasal | −0.352 (−0.605, −0.099) | 0.007 | −0.719 (−0.889, −0.550) | <0.0001 | −1.047 (−1.484, −0.610) | <0.0001 | 0.032 | 0.007 | 0.300 |
Superonasal | −0.269 (−0.587, 0.049) | 0.097 | −0.700 (−0.902, −0.498) | <0.0001 | −1.161 (−1.614, −0.709) | <0.0001 | 0.042 | 0.001 | 0.163 |
